A hand wearable body squeegee comprising a glove portion, a concave squeegee band, and a linear squeegee band.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7276552 | Compositions and methods for inhibiting protein on surfaces The use of NIPAM polymers to prevent or reduce the formation of protein deposits on the surfaces of medical devices is described. The invention is particularly directed to reduction of the adsorption of proteins on surfaces of contact lenses and other medical prosth... | 10/02/2007 |
| 7169755 | Solution for removing cataracts via liquefracture An improved solution for use in the removal of cataractous lenses via liquefracture is described. The liquefracture solution contains a viscosity-enhancing agent to increase the residence time of the solution in the heating chamber of the liquefracture handpiece, th... | 01/30/2007 |
| 7169767 | Ophthalmic compositions containing galactomannan polymers and borate The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also discloses methods... | 01/30/2007 |
| 7084130 | Intraocular irrigating solution having improved flow characteristics Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubb... | 08/01/2006 |
| 7045095 | Use of low molecular weight amino alcohols in ophthalmic compositions The use of low molecular weight amino alcohols in ophthalmic compositions is described. These compounds have been found to enhance the efficacy of anti-microbial preservatives. ... | 05/16/2006 |
| 7025958 | Use of amidoamines to treat or prevent acanthamoeba and fungal infections The use of amidoamines to treat or prevent infections attributable to Acanthamoeba and fungi is described. The amidoamines are highly effective against both Acanthamoeba and fungi, and are less toxic to delicate tissues that may become infected with th... | 04/11/2006 |
| 6995123 | Use of multifunctional surface active agents to clean contact lenses Cleaning compositions for contact lenses are described. The compositions contain multifunctional anionic surfactants that include at least two hydrophilic dissociating head groups. The multifunctional surfactants described (e.g., LED3A) possess both surface a... | 02/07/2006 |
| 6949218 | Use of low molecular weight amino alcohols in ophthalmic compositions The use of low molecular weight amino alcohols in ophthalmic compositions is described. These compounds have been found to enhance the efficacy of anti-microbial preservatives. ... | 09/27/2005 |
| 6936640 | Biguanide/quaternary ammonium containing copolymeric biocides and use thereof in pharmaceutical compositions Biguanide/quaternary ammonium compounds and the use of same as antimicrobial agents in pharmaceutical compositions are described. The biguanide/quaternary ammonium compounds are useful in the preservation of pharmaceutical compositions, particularly ophthalmic pharm... | 08/30/2005 |
| 6919321 | Ophthalmic lubricating solution adapted for use in lasik surgery Ocular lubricant solutions are described. The solutions are adapted to facilitate the formation of a corneal flap during LASIK surgery. The solutions contain one or more viscosity enhancing agents (e.g., chondroitin sulfate) in a substantially salt-free, ophthalmica... | 07/19/2005 |
| 6916958 | Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions Aminobiguanides and the use of same as antimicrobial agents in pharmaceutical compositions are disclosed. The aminobiguanides are useful in the preservation of pharmaceutical compositions, particularly ophthalmic pharmaceutical compositions and compositions for trea... | 07/12/2005 |
| 6878694 | Ophthalmic irrigating solution adapted for use in lasik surgery Compositions and methods for facilitating the formulation and closure of a corneal flap during LASIK surgery are described. The compositions and methods are based on the use of one or more viscosity-enhancing agents (e.g., chondroitin sulfate) to provide an ophthalm... | 04/12/2005 |
| 6849253 | Use of borate-polyol complexes in ophthalmic compositions Water-soluble borate-polyol complexes are useful as buffers and/or antimicrobials in aqueous ophthalmic compositions, including those containing polyvinyl alcohol. These compositions have greater antimicrobial activity than comparable compositions containing typical... | 02/01/2005 |
| 6838449 | Ophthalmic compositions containing galactomannan polymers and borate The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also discloses methods... | 01/04/2005 |
| 6740664 | Methods for treating otic and ophthalmic infections Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal cond... | 05/25/2004 |
| 6716830 | Ophthalmic antibiotic compositions containing moxifloxacin Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal cond... | 04/06/2004 |
| 6664294 | Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions Aminobiguanides and the use of same as antimicrobial agents in pharmaceutical compositions are disclosed. The aminobiguanides are useful in the preservation of pharmaceutical compositions, particularly ophthalmic pharmaceutical compositions and compositio... | 12/16/2003 |
| 6630135 | Use of sustained release antibiotic compositions in ophthalmic surgical procedures An improved method of sterilizing the field of surgery prior to an ophthalmic surgical procedure is described. The invention eliminates the need for painful and potentially traumatic injections of antibiotics by utilizing sustained release compositions wh... | 10/07/2003 |
| 6620797 | Artificial tear composition containing a combination of three demulcents Improved artificial tear compositions are described. The compositions are preferably formulated as sterile, isotonic solutions. The solutions contain a unique combination of three demulcents. The solutions preferably also contain one or more electrolytes ... | 09/16/2003 |
| 6583124 | Ophthalmic compositions containing galactomannan polymers and borate The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also disclo... | 06/24/2003 |
| 6509327 | Compositions and methods for treating otic, ophthalmic and nasal infections Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and... | 01/21/2003 |
| 6503497 | Use of borate-polyol complexes in ophthalmic compositions Water-soluble borate-polyol complexes are useful as buffers and/or antimicrobials in aqueous ophthalmic compositions, including those containing polyvinyl alcohol. These compositions have greater antimicrobial activity than comparable compositions contain... | 01/07/2003 |
| 6486138 | Ophthalmic compositions containing galactomannan polymers and borate The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also disclo... | 11/26/2002 |
| 6486215 | Solutions for treating contact lenses Contact lens care compositions for the treatment of hard contact lenses are disclosed. The compositions are useful for rinsing, cleaning, disinfecting and storing of hard contact lenses. The compositions contain an unique gelling system involving galactom... | 11/26/2002 |
| 6440964 | Compositions and methods for treating ophthalmic and otic infections Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and... | 08/27/2002 |
| 6433007 | Methods for the prevention and treatment of post-surgical complications Methods for treating post-surgical formation of cataracts or posterior capsule opacification are disclosed. The methods utilize compositions containing certain compounds having an anti-inflammatory and anti-oxidant moiety covalently linked by and amide an... | 08/13/2002 |
| 6423748 | Amido polybiguanides and the use thereof as antimicrobial agents Amido polybiguanides and their use as antimicrobial agents in pharmaceutical compositions are disclosed. A method of synthesis of amido polybiguanides is also disclosed. The amido polybiguanides are useful in the preservation of pharmaceutical composition... | 07/23/2002 |
| 6403609 | Ophthalmic compositions containing galactomannan polymers and borate The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also disclo... | 06/11/2002 |
| 6395746 | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation Methods of treating or preventing ophthalmic, otic, and nasal infections and attendant inflammation are described. The methods utilize ophthalmic, otic, and nasal compositions containing a new class of antibiotics (e.g. trovafloxacin). The compositions al... | 05/28/2002 |
| 6365636 | Use of borate-polyol complexes in ophthalmic compositions Water-soluble borate-polyol complexes are useful as buffers and/or antimicrobials in aqueous ophthalmic compositions, including those containing polyvinyl alcohol. These compositions have greater antimicrobial activity than comparable compositions contain... | 04/02/2002 |
| 6319464 | Use of low molecular weight amino alcohols in ophthalmic compositions The use of low molecular weight amino alcohols in ophthalmic boric solution is described herein. These compounds have been found to enhance the efficacy of antimicrobial preservatives. Particularly preferred amino alcohols are 2-amino-2-methyl-1-propanol ... | 11/20/2001 |
| 6316669 | Bis-amido polybiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions Bis-amido polybiguanides and their use as antimicrobial agents in pharmaceutical compositions are disclosed. A method of synthesis of bis-amido polybiguanides is also disclosed. The bis-amido polybiguanides are useful in the preservation of pharmaceutical... | 11/13/2001 |
| 6316506 | Conditioning solutions for contact lens care Contact lens care compositions for the treatment of hard contact lenses arc disclosed. The compositions are useful for rinsing, cleaning, disinfecting and storing of hard contact lenses. The compositions contain an unique gelling system involving galactom... | 11/13/2001 |
| 6143799 | Use of borate-polyol complexes in ophthalmic compositions Water-soluble borate-polyol complexes are useful as buffers and/or antimicrobials in aqueous ophthalmic compositions, including those containing polyvinyl alcohol. These compositions have greater antimicrobial activity than comparable compositions contain... | 11/07/2000 |
| 5985259 | Sustained release ophthalmic antibiotic compositions An improved method of sterilizing the field of surgery prior to an ophthalmic surgical procedure is described. The invention eliminates the need for painfull and potentially traumatic injections of antibiotics by utilizing sustained release compositions w... | 11/16/1999 |
| 5900213 | Use of diamines to disinfect and clean contact lenses and preserve ophthalmic compositions N,N-dialkyl and N'-alkylethylene diamines of the formula: ##STR1## wherein R, R1 and R2 are as described in the specification. The compounds are useful in disinfecting and cleaning contact lenses and preserving ophthalmic produc... | 05/04/1999 |
| 5811466 | Use of borate-polyol complexes in ophthalmic compositions Water-soluble borate-polyol complexes are useful as buffers and/or antimicrobials in aqueous ophthalmic compositions, including those containing polyvinyl alcohol. These compositions have greater antimicrobial activity than comparable compositions contain... | 09/22/1998 |
| 5741817 | Use of low molecular weight amino acids in ophthalmic compositions The use of glycine and other low molecular weight amino acids in ophthalmic compositions (e.g., preserved saline solutions) is described. These compounds have been found to enhance the efficacy of antimicrobial preservatives. The compounds also act as che... | 04/21/1998 |
| 5714463 | Use of growth factor and antimetabolite combination to prevent or retard fistula closure following glaucoma filtration surgery The intraocular use of combinations of stromal cell growth stimulators (e.g., TGF-ଲ) and antimetabolites (e.g., mitomycin C) in connection with glaucoma filtration surgery is described. The combination is applied to the surgical site to attract, mit... | 02/03/1998 |
| 5696091 | Use of growth factor and antimetabolite combination to prevent or retard secondary cataract formation The intraocular use of combinations of lens epithelial cell growth stimulators (e.g., TGF-ଲ) and antimetabolites (e.g., mitomycin C) is described. The combination is applied to the capsular bag to prevent or retard the formation of secondary catarac... | 12/09/1997 |